Advanced Renal Cell Carcinoma Terminated Phase 3 Trials for Sunitinib (DB01268)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01582672Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell CarcinomaTreatment